Oncology Focus : CAR-T and CAR-NK therapies represent ~30% of all cell and gene trials, with a strong focus on solid and hematological malignancies. Significant attention on gastrointestinal tract and ...

Phase 1: Discovery and Preclinical Phases: Identification and testing of potential drug compounds. Duration: 1 to 6 years.

Objectives Secondary prevention of rheumatoid arthritis (RA) is generally considered potentially impactful because the entire ...

Cybin Inc. (NYSE American:CYBN) (Cboe CA:CYBN) (“Cybin” or the “Company”), a clinical-stage breakthrough neuropsychiatry company committed to revoluti ...

The academic members of the research team that conducted the clinical trial recently demonstrated in a preclinical model that therapeutic inhibition of FasL significantly increased survival of mice ...

Experts have identified a cannabis compound called cannabinol (CBN) that appears to significantly enhance sleep quality.

Drug distributor Cencora plans to buy Retina Consultants of America from Webster Equity Partners in a $4.6 billion deal.  | ...

Members of Medigene management as expert speakers, Prof. Dolores Schendel, Chief Scientific Officer and Kirsty Crame, MD, Vice President, Clinical Strategy & Development Presentations and seminars ...

NMS Capital has exited its investment in Flourish Research, a US-based clinical trial organization, through a sale to Genstar Capital. No financial terms were disclosed.

Three distinguished faculty members across the Purdue University system have been elected as 2024 American Physical Society (APS) Fellows, a prestigious recognition given to scientists who have made ...

Health NZ's proposal to cut some chief clinical roles is "a declaration of war" on rural and regional hospitals, according to the senior doctors' union. Other frontline staff are skeptical of Te Whatu ...